Navigation Links
Anemia Treatment for Cancer Patients Might Not be a Good Idea.

Many patients being treated for cancer complain of feeling weak and tried, and doctors often prescribe //an anemia treatment to relieve these symptoms however a new study suggests otherwise.

Since anemia has been associated with worse prognosis after radiotherapy, the doctors assumed the treatment would make patients feel better and improve results of the therapy, as well.

Not so, report German researchers , their study finds treating anemia in cancer patients with the drug erythropoietin (epoetin beta) may actually interfere with cancer treatment. Patients who did not receive the treatment had about a 60-percent better chance of surviving their cancer without a relapse than those who did receive the treatment.

The study involved 351 patients who received either erythropoietin or a placebo about two weeks before undergoing radiotherapy for head and neck cancers. While the drug was effective in treating the symptoms of anemia among the patients, the poorer outcomes seen in the drug group led researchers to conclude the benefits may not be worth the risks.

Researchers say although epoetin beta efficiently corrects anemia among patients undergoing curative radiotherapy, it is not associated with improved cancer control or survival. On the contrary, erythropoietin might impair disease control when manifest cancer is irradiated. However further research is in progress on this subject.
'"/>




Page: 1

Related medicine news :

1. Anemia may Lead to Physical Decline
2. Anemia Treatment for Cancer Patients
3. Anemia Treatment for Cancer Patients
4. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
5. Treatment of Sickle Cell Anemia Using Gene Therapy.
6. Treating Sickle Cell Anemia using Healthy Stem Cells
7. Anemia from Malaria Linked to a Protein MIF
8. EPO Effective For Cancer Patients Suffering From Anemia
9. Amgen introduces Autoinjector For Treating Anemia
10. Anemia Affects Both Body and Mind
11. Exercise alleviates Anemia in Breast cancer patients
Post Your Comments:
(Date:1/7/2009)...HESTER, Ill., Jan. 7 BrainLAB, Inc., a leader in,...e medical treatments,announces a new, customer-foc... in consideration of continued growth and an expan... sales and support structures, customers will bene...anization. Streamlined,responsibilities, communica...
(Date:1/7/2009)...LAIRE, Wis., Jan. 7 A medical revolution emerges ...rt Hospital makes this connection,with its new Sma...iding,state-of-the-art treatment for neurosurgery,...www.newscom.com/cgi-bin/prnh/20081016/CLTH057 ) ,...ng technology, the Smart OR,helps neurosurgeons pe...
(Date:1/7/2009)...NAPOLIS, Jan. 7 Eli Lilly and Company,(NYSE: LL...urth quarter and,full year of 2008 on Thursday, Ja...nce call on that day with the investment community...al performance. , The conference call will be ...media and the general public can access a live web...
(Date:1/7/2009)..., Colo., Jan. 7 Zuma,s Rescue Ranch received its ... years of being self funded, Zuma,s Rescue Ranch c...ip! , , Zuma,s Rescue Ranch had a very busy 2008...y we have been working with Behavioral Health Inst... Psychotherapy for foster children. , , Please j...
Breaking Medicine News(10 mins):Health News:BrainLAB, Inc. Announces New, Streamlined Surgery Business Division 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 3
... a new study recommends radiologists examine the i...s can be performed in // the same office visit. Be...mmograms are abnormal, meaning a woman must come b...ograms turn out to be false-positives, meaning the...
...archers who observed rescue crews performing CPR o...eople significantly // more breaths than called fo...e the standards call for 12 to 15 breaths per minu...37 -- essentially causing their victims to hyperve...
...weight and obese children are on the fast track to...ndings. However with dietary changes // and more e...searchers used two noninvasive tests to measure at...plaque that leads to heart attacks and stroke -- i...
..., or severe acute respiratory syndrome, is a coron...animals. It emerged in southern China in late 2002...ur continents before it was contained last summer....d, and at least 774 died.Civet cats and other mong...
Other Medicine News:Health News:SARS vaccine shows promise in Animal Testing 2
(Date:1/7/2009)...Tiantan Puhua Hospital Stem Cells Center ( http://...using stem cells to effectively treat neurological...ienced additions to its medical and research staff...t capabilities for growing numbers of incoming int...e the distinguished Dr. Jiang Ping, who was named ...
(Date:1/6/2009)...sults from prior U.S., U.K. and China Trials , ,...s, Inc. (VTI), a development stage company targeti...nt has begun for a randomized, controlled, multi-c...Extracorporeal Liver Assist Device (ELAD) as a tre... under three protocols. The study is open for enro...
(Date:1/6/2009)...e/ -- In recent controlled studies conducted by Dr...ists found that the patented ingredient in Glyc,n ... ingredient to increase levels of nitric oxide (NO...trate (NOx) in human subjects. , , Nitric oxide...blood flow to the skeletal muscles. This is signi...
(Date:1/6/2009)...re-USNewswire/ -- Sequella, Inc., a clinical-stage...epidemic potential, announced today that SQ109, it...losis (TB), was the first drug approved for evalua...to Dynport Vaccine Company LLC and Quintiles Trans...stitute of Allergy and Infectious Diseases (NIAID)...
Breaking Medicine Technology:Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Oncolytics Biotech Inc Completes Dose Escalation in Combination REOLYSIN 28R 29 Docetaxel Trial 7068 1Oncolytics Biotech Inc Completes Dose Escalation in Combination REOLYSIN 28R 29 Docetaxel Trial 7068 2Oncolytics Biotech Inc Completes Dose Escalation in Combination REOLYSIN 28R 29 Docetaxel Trial 7068 3Surviving the revolution easier than withstanding human use and abuse 4415 1Surviving the revolution easier than withstanding human use and abuse 4415 2Surviving the revolution easier than withstanding human use and abuse 4415 3USC researchers identify alternate pathway that leads to palate development 4411 1USC researchers identify alternate pathway that leads to palate development 4411 2USC researchers identify alternate pathway that leads to palate development 4411 3Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM 121 an ErbB3 Antagonist 7062 1Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM 121 an ErbB3 Antagonist 7062 2Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM 121 an ErbB3 Antagonist 7062 3
...the CDC that none of its influenza vaccine (Fluvir...ted States for the current influenza season. In th...e anticipated American vaccine supply, medical off...gly alarmed about the scarcity of vaccine and the ...e seen if virulent new strains of flu or an abnorm...
...f rapid, easy-to-use diagnostic tests, many assays...ace to help clinicians assess dosage appropriatene...ence of drugs of abuse. Some of these products req...s are suitable for point of care use by medical pr..., Therapeutic drug monitoring measures the serum ...
Other Medicine Technology:Rapid Flu Tests May Prove Especially Helpful This Season 2Rapid Flu Tests May Prove Especially Helpful This Season 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 2Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 4
Stab incision blades color coded for simple and accurate identification
Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide.
...tions which enable procedure-specific modification...figurations to accomadate individual draping. Refr...cedure-specific modifications, Drape adapts to var...ate individual draping. Soft, comfortable material...
30, 6.0mm from end
Medicine Products: